The global medical cannabis market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is augmenting the growth of the market includes the rising aging population across the globe, as geriatric patients are more likely to develop chronic diseases and require more physician visits. Moreover, clinical trials, research and development (R&D) activities and commercialization of cannabis-based indications are some other factors, that are expected to catalyze the growth of the market during the forecast period. Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. It was used medicinally in ancient Indian, Chinese, Egyptian and Islamic cultures. 

Cannabis has application in the treatment of a wide range of diseases and symptoms, including cancer, chronic pain, depression, arthritis, diabetes, glaucoma, migraines, epilepsy, multiple sclerosis, acquired immunodeficiency syndrome (AIDS), amyotrophic lateral sclerosis (ALS), Alzheimer's, post-traumatic stress disorder (PTSD), Parkinson's and Tourette's. Cannabis has been approved for medical use in numerous countries, owing to its therapeutic benefits with varying degrees of legal restrictions. Cannabis is safer and has less severe side effects in comparison to other treatment options. It also finds usage along with other treatments either to enhance their efficacy or to combat adverse side effects. For instance, it is very effective in reducing nausea and increasing appetite among chemotherapy patients. Similarly, it is also used in combination with traditional opioid painkillers, which enables patients to reduce the dosage and frequency of opioids significantly and imparts greater pain relief. Hence, the growing use of cannabis in the treatment of several diseases is driving the market growth.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Canopy Growth Corporation, GW Pharmaceuticals, plc., Aurora Cannabis, Inc., and Aphria, Inc., among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Medical Cannabis Market Report by Segment

By Derivative 

• Cannabidiol (CBD)

• Tetrahydrocannabinol (THC)

• Creams

By Distribution Channel 

• Hospital Pharmacy

• Online Pharmacy

• Retail Pharmacy

By Application 

• Neurological Disorders Management

• Mental Health Management

• Pain Management

Global Medical Cannabis Market by Region